Connor Dowling, CEO of GenoTwin, has dedicated most of his career to the exciting intersection of life sciences and entrepreneurship. He uses this passion with GenoTwin’s efforts to help secure the world’s food supply. With five years of experience at Weill Cornell Medicine, he helped establish and run the BioVenture Entrepreneurship division, focusing on the commercialization of early-stage intellectual property. Passionate about the intersection of business and international issues, Connor pursued a master’s in global business administration from the Fletcher School at Tufts University. As CEO of GenoTwin, he is leading efforts to radically optimize biosecurity for the global food supply. GenoTwin is a member of the 2023 AgLaunch cohort working with leading farms and producers.